Insights from genome-wide association studies of drug response.

Abstract excerpt

Early genome-wide association studies (GWAS) using relatively small samples have identified both rare and common genetic variants with large impact on severe adverse drug reactions, dosing, and efficacy. Here we outline the challenges and recent successes of the GWAS approach in disease genetics and the ways in which these can be applied to pharmacogenomics for biological discovery, determination of heritability,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Related Side Effects and Adverse Reactions
• Share to Genetic Variation
• Share to Genome-Wide Association Study